|
1
|
Braillon A: Screening for colorectal
cancer at earlier ages: Putting the cart before the horse.
Gastroenterology. 156:15322019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Young GP, Rabeneck L and Winawer SJ: The
global paradigm shift in screening for colorectal cancer.
Gastroenterology. 156:843–851. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Andrea CE, Schalper KA, Sanmamed MF and
Melero I: Immunodivergence in metastatic colorectal cancer. Cancer
Cell. 34:876–878. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huyghe JR, Bien SA, Harrison TA, Kang HM,
Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK, et al:
Discovery of common and rare genetic risk variants for colorectal
cancer. Nat Genet. 51:76–87. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kageyama S, Hanada E, Ii H, Tomita K,
Yoshiki T and Kawauchi A: Gamma-glutamylcyclotransferase: A novel
target molecule for cancer diagnosis and treatment. Biomed Res Int.
2015:3452192015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Hyde AS, Simpson MA and Barycki JJ:
Emerging regulatory paradigms in glutathione metabolism. Adv Cancer
Res. 122:69–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amano T, Eishi Y, Yamada T, Uchida K,
Minegishi K, Tamura T, Kobayashi D, Hiroshi K, Suzuki T and Board
PG: Widespread expression of gamma-glutamyl cyclotransferase
suggests it is not a general tumor marker. J Histochem Cytochem.
60:76–86. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kageyama S, Isono T, Iwaki H, Wakabayashi
Y, Okada Y, Kontani K, Yoshimura K, Terai A, Arai Y and Yoshiki T:
Identification by proteomic analysis of calreticulin as a marker
for bladder cancer and evaluation of the diagnostic accuracy of its
detection in urine. Clin Chem. 50:857–866. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Uejima D, Nishijo K, Kajita Y, Ishibe T,
Aoyama T, Kageyama S, Iwaki H, Nakamura T, Iida H, Yoshiki T and
Toguchida J: Involvement of cancer biomarker C7orf24 in the growth
of human osteosarcoma. Anticancer Res. 31:1297–1305.
2011.PubMed/NCBI
|
|
10
|
Takemura K, Kawachi H, Eishi Y, Kitagaki
K, Negi M, Kobayashi M, Uchida K, Inoue J, Inazawa J, Kawano T and
Board P: γ-Glutamylcyclotransferase as a novel immunohistochemical
biomarker for the malignancy of esophageal squamous tumors. Hum
Pathol. 45:331–341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen SH, Yu N, Liu XY, Tan GW and Wang ZX:
Gamma-glutamylcyclotransferase promotes the growth of human glioma
cells by activating Notch-Akt signaling. Biochem Biophys Res
Commun. 471:616–620. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsumura K, Nakata S, Taniguchi K, Ii H,
Ashihara E, Kageyama S, Kawauchi A and Yoshiki T: Depletion of
gamma-glutamylcyclotransferase inhibits breast cancer cell growth
via cellular senescence induction mediated by CDK inhibitor
upregulation. BMC Cancer. 16:7482016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Yoshiya T, Nakata S, Taniguchi K,
Hidaka K, Tsuda S, Mochizuki M, Nishiuchi Y, Tsuda Y, Ito K, et al:
A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor
Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor
Growth in a Xenograft Mouse Model of Prostate Cancer. ChemMedChem.
13:155–163. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ii H, Yoshiya T, Nakata S, Taniguchi K,
Hidaka K, Tsuda S, Mochizuki M, Nishiuchi Y, Tsuda Y, Ito K, et al:
A novel prodrug of a γ-glutamylcyclotransferase inhibitor
suppresses cancer cell proliferation in vitro and inhibits tumor
growth in a xenograft mouse model of prostate cancer. Chemmedchem.
13:155–163. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kanehisa M, Sato Y, Furumichi M, Morishima
K and Tanabe M: New approach for understanding genome variations in
KEGG. Nucleic Acids Res. 47:D590–D595. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanehisa M: Toward understanding the
origin and evolution of cellular organisms. Protein Sci.
28:1947–1951. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
The Gene Ontology Consortium, . The Gene
Ontology resource: 20 years and still GOing strong. Nucleic Acids
Res. 47:D330–D338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, Wang X, Lai C, Zhang H and Lai M:
PMEPA1 induces EMT via a non-canonical TGF-β signalling in
colorectal cancer. J Cell Mol Med. 23:3603–3615. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang R, Hoang BH, Kubo T, Kawano H, Chou
A, Sowers R, Huvos AG, Meyers PA, Healey JH and Gorlick R:
Over-expression of parathyroid hormone Type 1 receptor confers an
aggressive phenotype in osteosarcoma. Int J Cancer. 121:943–954.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ganesh K, Stadler ZK, Cercek A, Mendelsohn
RB, Shia J, Segal NH and Diaz LJ Jr: Immunotherapy in colorectal
cancer: Rationale, challenges and potential. Nat Rev Gastroenterol
Hepatol. 16:361–375. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Valle L, de Voer RM, Goldberg Y, Sjursen
W, Försti A, Ruiz-Ponte C, Caldés T, Garré P, Olsen MF, Nordling M,
et al: Update on genetic predisposition to colorectal cancer and
polyposis. Mol Aspects Med. 69:10–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh M, Yelle N, Venugopal C and Singh
SK: EMT: Mechanisms and therapeutic implications. Pharmacol Ther.
182:80–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu Y, Wang C, Becker SA, Hurst K,
Nogueira LM, Findlay VJ and Camp ER: miR-145 antagonizes
SNAI1-mediated stemness and radiation resistance in colorectal
cancer. Mol Ther. 26:744–754. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei R, Xiao Y, Song Y, Yuan H, Luo J and
Xu W: FAT4 regulates the EMT and autophagy in colorectal cancer
cells in part via the PI3K-AKT signaling axis. J Exp Clin Cancer
Res. 38:1122019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun J, Zhang T, Cheng M, Hong L, Zhang C,
Xie M, Sun P, Fan R, Wang Z, Wang L and Zhong J: TRIM29 facilitates
the epithelial-to-mesenchymal transition and the progression of
colorectal cancer via the activation of the Wnt/β-catenin signaling
pathway. J Exp Clin Cancer Res. 38:1042019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang W, Chen L, Xiang H, Hu C, Shi W,
Dong P and Lv W: Knockdown of GGCT inhibits cell proliferation and
induces late apoptosis in human gastric cancer. BMC Biochem.
17:192016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kageyama S, Ii H, Taniguchi K, Kubota S,
Yoshida T, Isono T, Chano T, Yoshiya T, Ito K, Yoshiki T, et al:
Mechanisms of tumor growth inhibition by depletion of
γ-glutamylcyclotransferase (GGCT): A novel molecular target for
anticancer therapy. Int J Mol Sci. 19:E20542018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Zhao W, Zhao Z, Wu J, Chen L, Ma Y,
Li Q, Lu D, Jin L and Wang J: IL1B gene polymorphisms, age and the
risk of non-small cell lung cancer in a Chinese population. Lung
Cancer. 89:232–237. 2015. View Article : Google Scholar : PubMed/NCBI
|
